PKM and cancer: Recent studies have confirmed the cytotoxic effects of vitamin K analogues in cancer cells and demonstrated that treatment of HeLa cells with two vitamin K analogues (VK3 and VK5) resulted in reduced cell survival through modulation of glycolysis and PKM2 activity [172].